Digg
Del.icio.us
Yahoo
Google
Newsvine
News Room
News Listing
-
SCRI in the News
February 02, 2012
-
NBJ announces the Forty Under 40 class of 2012
January 25, 2012
Congratulations are in order for the Nashville Business Journal’s Forty Under 40 class of 2012. The following 40 winners, first named during a reveal party Tuesday night at Nashville City Club , were deemed to be making a difference in their companies and community by a panel of judges.
-
World-class care right here at home
January 23, 2012
When it arrives, a diagnosis of cancer can be among the most devastating of news to a patient and their families. For local residents, the course of treatment has often meant weekly trips to nearby Murfreesboro or Nashville for chemotherapy.
-
SARAH CANNON RESEARCH INSTITUTE TO PRESENT AT ASCO GASTROINTESTINAL CANCERS SYMPOSIUM
January 20, 2012
NASHVILLE, TN, Jan. 20, 2012 – Sarah Cannon Research Institute (SCRI) physicians authored four abstracts accepted for presentation at the ASCO 2012 Gastrointestinal Cancers Symposium, which runs from Jan. 19-21 in San Francisco, CA.
-
Nashville Business Journal Healthiest Employers
December 19, 2011
The Nashville Business Journal is pleased to announce the honorees for this year’s Healthiest Employers Awards.
-
Sarah Cannon Research Institute Presents Findings of Blood Cancer Clinical Trials at National Conference
December 10, 2011
NASHVILLE, TN, Dec. 10, 2011 – Sarah Cannon Research Institute (SCRI) investigators will present the findings of several important blood cancer trials during the 53rd Annual Meeting of the American Society of Hematology (ASH) in San Diego December 10-13.
-
SARAH CANNON RESEARCH INSTITUTE INVESTIGATOR AUTHORS TEN STUDIES FOR PRESENTATION AT SAN ANTONIO BREAST CANCER SYMPOSIUM
December 06, 2011
NASHVILLE, TN., Dec. 6, 2011 – Denise A. Yardley, M.D., senior investigator, breast cancer research for Sarah Cannon Research Institute (SCRI) serves as primary or co-author of ten breast cancer clinical trial abstracts that have been accepted for presentation during the 34th Annual San Antonio Breast Cancer Symposium (SABCS), which takes place Dec. 6-10 in San Antonio, Texas.
-
AHA Honors area Fit-Friendly companies
November 22, 2011
The American Heart Association has awarded 2011 Fit-Friendly recognition to 46 Middle Tennessee companies, for their notable efforts to promote physical activity and health in the workplace, according to an AHA news release.
-
Nashville hospitals to hold trials for promising cancer vaccines
November 13, 2011
Nashville hospitals have something new in their arsenal against the most deadly cancers — emerging vaccines that spur people’s immune systems to target tumors.
-
Sarah Cannon Research Institute To Present Clinical Trial Findings At International Conference For Oncology Drug Development
November 12, 2011
Physician leaders author eight presentations
-
Weekly SCRI Mentions
November 10, 2011
This is a new addition to our news room that will link to any articles published about Sarah Cannon Research Institute.
-
2012 Annual Network Meeting
November 09, 2011
-
LHC Delegation Returns from Wall Street a Bit Wiser
November 02, 2011
Speakers, Panelists Share Outlook on Financial Landscape
-
Cancer fights offers more for business
September 12, 2011
New technology, treatment options pave way for more companies to enter
-
SARAH CANNON RESEARCH INSTITUTE (SCRI) ABSTRACT ACCEPTED FOR PRESENTATION AT ASCO BREAST CANCER SYMPOSIUM
September 07, 2011
NASHVILLE, TN., Sept. 7, 2011 – SCRI Breast Cancer Senior Investigator Denise A. Yardley, M.D. will present findings of ENCORE 301, an advanced breast cancer study, at the 2011 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium September 8-10 in San Francisco, CA.
-
Vemurafenib Receives Approval for Metastatic Melanoma
August 19, 2011
The FDA approved the melanoma drug vemurafenib along with a companion diagnostic test in a move that was hailed as an advance for both patients and personalized medicine.
-
U.S. News Media Group Releases List of 'Top Doctors'
July 26, 2011
Searchable directory builds on Best Hospitals rankings
-
Sarah Cannon Research Institute Abstracts Accepted for Presentation at the World Conference on Lung Cancer
June 30, 2011
NASHVILLE, TN, June 30, 2011 – The International Association for the Study of Lung Cancer (IASLC) has chosen four Sarah Cannon Research Institute (SCRI) abstracts for presentation, including a Conference President’s Selection, at the 14th World Conference on Lung Cancer, which takes place July 3-7 in Amsterdam, The Netherlands.
-
SARAH CANNON RESEARCH INSTITUTE NAMES DIRECTOR AND EXECUTIVE DIRECTOR OF ITS DRUG DEVELOPMENT PROGRAM
June 02, 2011
NASHVILLE, TN, June 2, 2011 – Sarah Cannon Research Institute (SCRI) has promoted Jeffrey R. Infante, M.D., to Director, Drug Development for the Nashville based program where he previously served as associate director. Howard A. “Skip” Burris III, M.D., chief medical officer for the organization, will assume the role of executive director for the overall drug development initiative.
-
Yale Cancer Center, Smilow Cancer Hospital, and Sarah Cannon Research Institute Announce Intent to Collaborate Scientifically to Advance Cancer Research
June 01, 2011
-
American Society of Clinical Oncology (ASCO) Accepted 52 Sarah Cannon Research Institute Abstracts for Presentation at 2011 Annual Meeting
June 01, 2011
Two abstracts chosen for the Best of ASCO program and three for a clinical science symposium
-
SARAH CANNON RESEARCH INSTITUTE ESTABLISHES CARDIOVASCULAR RESEARCH STRATEGIC SITE AT NORTHSIDE HOSPITAL
June 01, 2011
NASHVILLE, TN, June 2, 2011 – Sarah Cannon Research Institute (SCRI), one of the largest global clinical research programs, has signed an agreement with The Tampa Bay Heart Institute at Northside Hospital in St. Petersburg, FL, as a cardiovascular clinical research strategic site.
-
Abiraterone and Increased Survival in Metastatic Prostate Cancer
May 27, 2011
Lead article published Wednesday May 25, 2011 in the New England Journal of Medicine featuring SCRI Chief Scientific Officer John D. Hainsworth, M.D. (as co-author of study) on a phase 3 abiraterone study.
-
Myeloma Research To Be Presented At The American Society of Clinical Oncology’s 47th Annual Meeting (ASCO 2011)
May 27, 2011
Dr. Jesus Berdeja to present results from a Phase 1 study of lorvotuzumab mertansine in combination with Revlimid and dexamethasone in a specific subset of relapsed / refractory myeloma patients whose myeloma cells contain the CD56 protein.
-
Genomic Health Announces Ten Studies
May 27, 2011
Genomic Health Announces Ten Studies Covering Breast, Colon And Prostate Cancers Accepted For Presentation At The American Society Of Clinical Oncology (ASCO) Annual Meeting
-
MetMAb in Combination with Tarceva Doubled the Time People with Lung Cancer Lived Without Their Disease Getting Worse
May 27, 2011
-
Bevacizumab and Erlotinib show promise for kidney cancer
May 27, 2011
-
Roche Drug Tandem Extends Life of Some Lung-Cancer Patients
May 19, 2011
A Roche Holding AG (ROG) experimental drug called MetMab, used with another medicine, extended the lives of lung-cancer patients whose tumors had high levels of a protein known to trigger the disease and help it spread, a study found.
-
Nine Physicians Associated with Sarah Cannon Research Institute Named to Best Doctors List
May 03, 2011
NASHVILLE, TN., May 3, 2011 -- Nine Tennessee physicians affiliated with the Sarah Cannon Research Institute (SCRI) were chosen by fellow physicians as Best Doctors in America for 2011-2012.
-
SARAH CANNON RESEARCH INSTITUTE (SCRI) TO PRESENT AT AACR 102ND ANNUAL MEETING
April 02, 2011
Inhibiting two prominent pathways activated in cancer cells appears encouraging in a clinical study • Combination therapy targets MEK and PI3K pathways • Phase I trials of single agent MEK and PI3K pathway inhibitors alone have shown signs of anti-tumor activity • Abstract to be presented at AACR meeting on Sunday, April 3
-
New CFO, CIO for Sarah Cannon Research
March 14, 2011
Former HCA worker to lead financial group at institute Published March 14, 2011 by NashvillePost.com